PankoMab-GEX™ Versus Placebo as Maintenance Therapy in Advanced Ovarian Cancer
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01899599 |
Recruitment Status :
Completed
First Posted : July 15, 2013
Last Update Posted : October 22, 2020
|
Sponsor:
Glycotope GmbH
Information provided by (Responsible Party):
Glycotope GmbH
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | April 20, 2017 |
Actual Study Completion Date : | July 28, 2017 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):